| Title | Author(s) | Year | View Count |
 | Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals | Zhang, L; Zhang, F; Yu, W; He, T; Yu, J; Yi, CE; Ba, L; Li, W; Farzan, M; Chen, Z; Yuen, KY; Ho, D | 2006 | 65 |
 | Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region | Chen, Z; Zhang, L; Qin, C; Ba, L; Yi, CE; Zhang, F; Wei, Q; He, T; Yu, W; Yu, J; Gao, H; Tu, X; Gettie, A; Farzan, M; Yuen, KY; Ho, DD | 2005 | 266 |
| Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2 | Li, W; Zhang, C; Sui, J; Kuhn, JH; Moore, MJ; Luo, S; Wong, SK; Huang, IC; Xu, K; Vasilieva, N; Murakami, A; He, Y; Marasco, WA; Guan, Y; Choe, H; Farzan, M | 2005 | 238 |
| Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120 | Huang, CC; Venturi, M; Majeed, S; Moore, MJ; Phogat, S; Zhang, MY; Dimitrov, DS; Hendrickson, WA; Robinson, J; Sodroski, J; Wyatt, R; Choe, H; Farzan, M; Kwong, PD | 2004 | 61 |
|
